Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 3Cytokine Release Syndrome 2Schwannomatosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pain 1Neurilemmoma 1Neoplasms, Plasma Cell 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Large Granular Lymphocytic 1Immunoglobulin Light-chain Amyloidosis 1Chronic Pain 1Burkitt Lymphoma 1Advanced Malignant Solid Neoplasm 1

Interventions

Acetaminophen 4Surveys and Questionnaires 3Saline Solution 3nabiximols 2Standard of Care 2Radiofrequency Ablation 2Oxycodone 2Music Therapy 2Morphine 2Methods 2Electroacupuncture 2Dronabinol 2siltuximab 1pegfilgrastim 1oxycodone-acetaminophen 1erenumab 1Yoga 1Xylitol 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1Transcranial Direct Current Stimulation 1Therapeutics 1Telemedicine 1STAMP-I protocol 1Remifentanil 1Range of Motion, Articular 1Psychiatric Rehabilitation 1Preoperative Exercise 1Physical Therapy Modalities 1Pentoxifylline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × siltuximab × 1 year × Clear all
NCT05684692 2026-04-23

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

Massachusetts General Hospital

Phase 2 Recruiting
40 enrolled

Schwannomatosis, Neurilemmoma, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡